azimexon has been researched along with Hodgkin Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goutner, A; Huchet, R; Mathé, G; Thomas, Y | 1 |
| Advani, SH; Gangal, SG; Ghogale, SR | 1 |
| Advani, SH; Gangal, SG; Shetye, MR; Somasundaram, R | 1 |
3 other study(ies) available for azimexon and Hodgkin Disease
| Article | Year |
|---|---|
[Immune monitoring of the cancer patient: suppressor cells and NK cells].
Topics: Adjuvants, Immunologic; Aziridines; Cytotoxicity, Immunologic; Drug Hypersensitivity; Hodgkin Disease; Humans; Hypersensitivity, Delayed; Interferons; Killer Cells, Natural; Lung Neoplasms; Lymphokines; T-Lymphocytes, Regulatory | 1980 |
Effect of BM 12531 on rosette formation and in vitro functions of peripheral blood lymphocytes obtained from healthy donors and cancer patients.
Topics: Aziridines; Azirines; Hodgkin Disease; Humans; In Vitro Techniques; Leukocyte Migration-Inhibitory Factors; Multiple Myeloma; Rosette Formation; T-Lymphocytes | 1981 |
Effect of BM 12 531 on in vitro induction of suppressor cells by concanavalin A in cancer patients and normal healthy donors.
Topics: Aziridines; Azirines; Cells, Cultured; Concanavalin A; Hodgkin Disease; Humans; Leukemia, Myeloid; Lymphocyte Activation; T-Lymphocytes, Regulatory | 1986 |